We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No, after you

13 July 2007 By Robert Cyran

Companies put on the block often are covered in warts look at troubled contact lens group Bausch & Lomb. It makes an attractive target for rival Advanced Medical. But big shareholder ValueAct says private equity should spiff B&L up first.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)